Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Short Interest Down 7.5% in November

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 1,110,000 shares, a drop of 7.5% from the October 31st total of 1,200,000 shares. Currently, 2.0% of the company’s stock are sold short. Based on an average daily volume of 316,700 shares, the short-interest ratio is currently 3.5 days.

Hedge Funds Weigh In On Aveanna Healthcare

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Aveanna Healthcare by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares during the period. Geode Capital Management LLC boosted its stake in Aveanna Healthcare by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,401,016 shares of the company’s stock valued at $7,287,000 after buying an additional 63,190 shares during the period. State Street Corp boosted its stake in Aveanna Healthcare by 0.9% during the third quarter. State Street Corp now owns 1,039,920 shares of the company’s stock valued at $5,408,000 after buying an additional 9,446 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Aveanna Healthcare by 3.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 462,659 shares of the company’s stock valued at $2,406,000 after buying an additional 17,522 shares during the period. Finally, Jacobs Levy Equity Management Inc. grew its position in Aveanna Healthcare by 297.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 355,340 shares of the company’s stock worth $1,848,000 after buying an additional 265,969 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Trading Up 0.7 %

AVAH opened at $5.85 on Tuesday. The company has a 50 day moving average of $5.23 and a 200 day moving average of $4.30. Aveanna Healthcare has a 12 month low of $2.00 and a 12 month high of $6.19. The company has a market cap of $1.13 billion, a PE ratio of -17.15 and a beta of 2.13.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The company had revenue of $509.02 million during the quarter, compared to the consensus estimate of $495.80 million. During the same quarter in the prior year, the business earned ($0.05) EPS. Research analysts forecast that Aveanna Healthcare will post -0.09 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

AVAH has been the subject of a number of recent analyst reports. UBS Group upped their price objective on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the stock a “sell” rating in a research report on Friday, August 9th. Deutsche Bank Aktiengesellschaft lifted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the stock a “buy” rating in a report on Friday, August 9th. Finally, Royal Bank of Canada upped their price objective on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research note on Friday, August 9th.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.